- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in New Zealand
Total 469 results
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaUnited States Department of Defense; Advanced Accelerator Applications; Australian... and other collaboratorsActive, not recruitingMetastatic Hormone Naive Prostate CancerAustralia
-
SanofiCompleted
-
Roswell Park Cancer InstituteAbbVieCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma...United States
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
US Oncology ResearchPfizerCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseCompletedCastration Resistant Metastatic Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterMemorial Sloan Kettering Cancer Center; University of California, San FranciscoActive, not recruitingSolid Tumor | Metastatic Cancer | Metastatic Castration Resistant Prostate CancerUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCTerminatedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Memorial Sloan Kettering Cancer CenterUniversity of North Carolina; New York-Presbyterian Hospital Cornell Medical...CompletedPain | Metastatic Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
Opna-IO LLCTerminatedMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
Epizyme, Inc.Active, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, Belgium
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Janux TherapeuticsRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Castration Resistant Prostatic CancerUnited States, Australia
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Weill Medical College of Cornell UniversityCompletedMetastatic Prostate CancerUnited States
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Carolina Research Professionals, LLCBayerUnknownProstate Cancer MetastaticUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Roswell Park Cancer InstituteWithdrawnCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone | PSA...United States
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCActive, not recruitingProstate Cancer MetastaticUnited States
-
Corcept TherapeuticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States, United Kingdom
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Veru Inc.CompletedProstate Cancer MetastaticUnited States
-
Hookipa Biotech GmbHRecruitingProstate Cancer MetastaticUnited States
-
Yale UniversityDendreonRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Mark SteinRegeneron PharmaceuticalsActive, not recruitingProstate Cancer MetastaticUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States